Serum angiopoietin-2 and soluble VEGFR-2 levels predict malignancy of ovarian neoplasm and poor prognosis in epithelial ovarian cancer

Por Sallinen, Hanna, Heikura, Tommi, Koponen, Jonna, Kosma, Veli-Matti, Heinonen, Seppo, Ylä-Herttuala, Seppo, Anttila, Maarit
Publicado em 2014

Antiangiogenic Gene Therapy With Soluble VEGFR-1, -2, and -3 Reduces the Growth of Solid Human Ovarian Carcinoma in Mice

Por Sallinen, Hanna, Anttila, Maarit, Narvainen, Johanna, Koponen, Jonna, Hamalainen, Kirsi, Kholova, Ivana, Heikura, Tommi, Toivanen, Pyry, Kosma, Veli-Matti, Heinonen, Seppo, Alitalo, Kari, Yla-Herttuala, Seppo
Publicado em 2008